The National Pharmaceutical Council: Endorsing the Construction of Imaginary Worlds In Health Technology Assessment

May 12, 2020 Dr Paul Langely 1511 Views

Paul C. Langley, Ph.D., Adjunct Professor College of Pharmacy, University of Minnesota, MN

The Maimon Working Papers are free to download (in PDF format) at the bottom of the page.

Working-Paper-No.-12-May-2020 Download

One thought on “The National Pharmaceutical Council: Endorsing the Construction of Imaginary Worlds In Health Technology Assessment”

Pingback: THE ICER FANTASY

Comments are closed.

European Society of Cardiology(ESC)
European Respiratory Society (ERS)
European Alliance of Associations for Rheumatology (EULAR)
European Society for Medical Oncology (ESMO)
European Academy of Neurology (EAN)
European Psychiatric Association (EPA)
American College of Cardiology (ACC)
American Heart Association (AHA)
American Society of Clinical Oncology (ASCO)
American College of Rheumatology (ACR)
American Academy of Neurology (AAN)
American Thoracic Society (ATS)
Canadian Cardiovascular Society (CCS)
Canadian Rheumatology Association
Canadian Thoracic Society
European Organisation for Research and Treatment of Cancer (EORTC)
International Society for Quality of Life Research (ISOQOL)
International Consortium for Health Outcomes Measurement (ICHOM).
International Osteoporosis Foundation (IOF)
Movement Disorder Society (MDS)
American Pain Society (APS)
Canadian Pain Society (CPS)
British Pain Society (BPS)
European Pain Federation (EFIC)